Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

2.

Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis.

Phung OJ, Sobieraj DM, Engel SS, Rajpathak SN.

Diabetes Obes Metab. 2014 May;16(5):410-7. doi: 10.1111/dom.12233. Epub 2013 Dec 16. Review.

PMID:
24205921
3.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
4.

Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK.

Beale S, Bagust A, Shearer AT, Martin A, Hulme L.

Pharmacoeconomics. 2006;24 Suppl 1:21-34. Review.

PMID:
16800160
5.

Lessons from UK prospective diabetes study.

Turner RC, Holman RR.

Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S151-7. Review.

PMID:
8529508
6.

Treatment of non-insulin-dependent diabetes mellitus with metformin.

Guthrie R.

J Am Board Fam Pract. 1997 May-Jun;10(3):213-21. Review.

PMID:
9159660
7.

Oral antihyperglycemic therapy for type 2 diabetes: scientific review.

Inzucchi SE.

JAMA. 2002 Jan 16;287(3):360-72. Review.

PMID:
11790216
8.

Glimepiride: evidence-based facts, trends, and observations (GIFTS). [corrected].

Basit A, Riaz M, Fawwad A.

Vasc Health Risk Manag. 2012;8:463-72. doi: 10.2147/HIV.S33194. Epub 2012 Aug 15. Review. Erratum in: Vasc Health Risk Manag. 2013;9:1.

9.

Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review.

Costello RB, Dwyer JT, Saldanha L, Bailey RL, Merkel J, Wambogo E.

J Acad Nutr Diet. 2016 Nov;116(11):1794-1802. doi: 10.1016/j.jand.2016.07.015. Epub 2016 Sep 8. Review.

PMID:
27618575
10.

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.

Holman RR.

Metabolism. 2006 May;55(5 Suppl 1):S2-5. Review.

PMID:
16631806
11.

UKPDS and beyond: into the next millennium. United Kingdom Prospective Diabetes Study.

Krentz AJ.

Diabetes Obes Metab. 1999 Jan;1(1):13-22. Review. No abstract available.

PMID:
11221807
12.

Glucose control in the UKPDS: what did we learn?

Gale EA.

Diabet Med. 2008 Aug;25 Suppl 2:9-12. doi: 10.1111/j.1464-5491.2008.02503.x. Review.

PMID:
18717972
13.

Oral pharmacologic management of type 2 diabetes.

Riddle MC.

Am Fam Physician. 1999 Dec;60(9):2613-20. Review.

14.

Treatment strategies for patients with non-insulin-dependent diabetes mellitus.

Boden G.

Am J Med. 1985 Aug 23;79(2B):23-6. Review.

PMID:
2994471
15.

Long-term studies of treatments for type 2 diabetes.

Caballero AE.

Postgrad Med. 2017 Apr;129(3):352-365. doi: 10.1080/00325481.2017.1265417. Epub 2016 Dec 14. Review.

PMID:
27882816
16.

[New treatment strategies for type-2 diabetes?].

Halimi S.

Presse Med. 2005 Oct 22;34(18):1287-92. Review. French.

PMID:
16269991
17.

Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus.

Campbell RK.

Ann Pharmacother. 1998 Oct;32(10):1044-52. Review.

PMID:
9793597
18.

Chronic fructose substitution for glucose or sucrose in food or beverages has little effect on fasting blood glucose, insulin, or triglycerides: a systematic review and meta-analysis.

Evans RA, Frese M, Romero J, Cunningham JH, Mills KE.

Am J Clin Nutr. 2017 Aug;106(2):519-529. doi: 10.3945/ajcn.116.145169. Epub 2017 Jun 7. Review.

PMID:
28592603
19.

Metformin: an antihyperglycemic agent for treatment of type II diabetes.

Melchior WR, Jaber LA.

Ann Pharmacother. 1996 Feb;30(2):158-64. Review.

PMID:
8835050
20.

Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.

Lipska KJ, Krumholz H, Soones T, Lee SJ.

JAMA. 2016 Mar 8;315(10):1034-45. doi: 10.1001/jama.2016.0299. Review.

Supplemental Content

Support Center